(Hypertension. 1997;30:596.)
© 1997 American Heart Association, Inc.
Articles |
From the Departamento de Fisiología y Farmacología (R.A.B., E.C.H.), Sección de Graduados (C.C.H.), Escuela Superior de Medicina del IPN, Plan de San Luis y Díaz Mirón, Casco de Santo Tomás; and the Departamento de Farmacología (B.E.) and the Sección de Terapéutica Experimental (E.H.), CINVESTAV IPN, Mexico.
Correspondence to Rosa A. Bobadilla, MD, Dept de Fisiología y Farmacología, Escuela Superior de Medicina del IPN, Plan de San Luis y Díaz Mirón, Casco de Santo Tomás, Mexico DF, CP 11340.
| Abstract |
|---|
|
|
|---|
Key Words: pregnancy rats aorta nitric oxide endothelium-derived factors
| Introduction |
|---|
|
|
|---|
There is evidence that pregnancy-attenuated response to vasoconstrictors may vary depending on the vascular territory under study. Thus, for example, the influence of pregnancy has been observed in the uterine but not in the carotid artery of guinea pigs.8 Furthermore, it has been shown that the regional variation in the response of the guinea pig thoracic aorta to contractile agonists is augmented during pregnancy.9 The distribution of estrogen receptors has been identified in the baboon thoracic aorta, with an increasing concentration moving proximal to distal.10 Therefore, since the distribution of estrogen receptors may be regionalized, the regional variation in the response of aorta (and other vessels) to contractile agonists could be related to differential sensibility to the hormonal influence associated with, or independent of, the specific mechanisms that reflect the interaction between smooth muscle activation and the release of endothelial substances.
Increased basal release of NO secondary to elevated estrogen plasma concentrations has been proposed as the major mechanism responsible of the cardiovascular changes observed during pregnancy,11 12 but this assumption has not been fully demonstrated,13 and other mechanisms involved have also been proposed.14 Specifically, considering that physiological (or pathological) alterations in endothelial function can be characterized, at least in part, as attenuated or enhanced production and release of other EDRFs than NO, such as PGI2 and EDHF, the participation of the latter two factors in pregnancy-dependent cardiovascular changes needs to be thoroughly evaluated.
We have observed a more remarkable influence of pregnancy in the response to methoxamine in the abdominal compared with the thoracic segments of the rat aorta.15 However, NO mediation of the attenuated response to methoxamine was demonstrated in the thoracic aortic segment but could not be sustained in the abdominal aortic segment. Thus, the mediator responsible for the attenuated contractile response (to vasoactive substances) of the abdominal rat aorta during pregnancy still requires elucidation. Accordingly, the present studies were undertaken to investigate the participation of endothelium-derived vasorelaxant substances on the vascular responses of the thoracic and abdominal aorta from pregnant and nonpregnant rats.
| Methods |
|---|
|
|
|---|
After slight anesthesia with ether, rats were killed by a blow on the head. Immediately, a midline abdominal and thoracic laparotomy was performed, and the entire descending aorta was excised and placed in iced oxygenated Krebs solution composed of the following (in mmol/L): NaCl 118, KCl 4.8, KH2PO4 1.2, MgSO4.7H2O 1.2, CaCl2.2H2O 2.5, NaHCO3 25.0, dextrose 11.7, calcium disodium EDTA 0.026,16 and propranolol (10-5 mol/L). The specimens were cleaned of adherent fat and adjacent connective tissues. Using the diaphragm as a reference point, two 5-mm-long aortic segments proximal and distal to it were removed and discarded. The remaining portions of either the thoracic or abdominal aorta were cut into equal rings, approximately 5 mm in length. Two rings from each aortic segment were used in each experiment. For isometric tension measurement, each ring was threaded onto two nichrome hooks and suspended between a stationary support at the bottom of the chamber and an isometric force transducer (Statham FT03) connected to a 7D Grass polygraph (Quincy). Rings were placed in an isolated organ chamber of 10-mL capacity containing warmed (37°C), pH 7.4 Krebs buffer aerated with 95% O2/5% CO2. Based on KCl preliminary experiments, the rings were stretched to a basal 3 and 2 g (thoracic and abdominal aorta rings, respectively). Afterwards, responses to phenylephrine (10-7 mol/L) were obtained every 20 minutes until maximal reactivity was observed (usually 2 hours). The functional integrity of the endothelium was pharmacologically assessed by an immediate relaxation induced by ACh (10-6 mol/L) in rings contracted by phenylephrine (10-6 mol/L).
Experimental Protocols
Cumulative concentration-response curves to acetylcholine
(10-9 to 10-4
mol/L) were done in aorta rings from pregnant and nonpregnant
rats submaximally contracted with phenylephrine
(10-6 mol/L). To determine the
participation of NO in ACh-induced relaxation, aortic rings were
pretreated with a selective NO synthase (NOS) inhibitor,
L-NAME (10-5
mol/L)17 for 30 minutes prior to ACh
concentration-response measurements. To determine the effect of
cyclooxygenase products on ACh-stimulated
relaxation, the aortic rings (as above) were pretreated for 30 minutes
with 10-5 mol/L
indomethacin, a concentration previously reported to
effectively inhibit cyclooxygenase18
before the concentration-response curve to ACh. Finally, to evaluate
the contribution of cytochrome P450 (cyt P450)derived
arachidonic acid metabolites on pregnancy-increased
endothelium-dependent relaxation, ACh
concentration-response measurements were repeated in aortic rings
pretreated (30 minutes) with clotrimazole
(10-5 mol/L). Clotrimazole is
considered to effectively inhibit endothelium-dependent
hyperpolarization at the concentration used in this
work.19 36 In all experiments, one preparation was run in
parallel with the experimental tissues, but received no enzymatic
inhibitor drug, and was used to determine any
time-dependent changes in agonist sensitivity.
Determination of Nitrites (NO2-)
Aortas were obtained from pregnant (day 19 to 21) and
nonpregnant rats (n=5 for each group), separated into thoracic and
abdominal segments, and cut into rings 3 to 4 mm in length
(approximately 8 rings per segment). Each group of rings was incubated
separately in 5 mL of Krebs-bicarbonate solution at 37°C in a shaking
water bath. The solution was changed every 15 minutes until all blood
elements were eliminated (30 to 45 minutes). After this procedure,
groups of rings were incubated (for 30 minutes at 37°C) in a shaking
water bath containing either acetylcholine
(10-4 mol/L) in a total volume of 1 mL
of Krebs (treatment groups) or an equal volume of Krebs in control
groups. At the end of this period, two 500-µL aliquots of the
solution were removed. Duplicate samples were incubated with 40 µL of
a variant of Griess reagent (20 µL trichloroacetic acid 50%, 10 µL
procainamide 2%, and 10 µL N-N naftiletilendiamine 1% in
water) to form a stable azo-dye, which was measured by
spectrophotometry at 548 nm. Nitrites were determined by interpolating
average absorbance values in a standard curve. This assay detects
nitrites in the range 10-7 to
10-4 mol/L. Rings were dried at 60°C
in an oven for 1 hour, and the dry weight was calculated. Data obtained
are expressed as mol · mg-1 · 30
min-1.
Drugs
Fresh solutions of the following drugs were prepared for each
experiment: L-phenylephrine acetylcholine, L-NAME,
clotrimazole, procainamide, and N-N naftiletilendiamine
(all from Sigma Chemical Co). All drugs were dissolved in distilled
water (stock solutions), and dilutions were prepared with Krebs
solution. Sodium carbonate 3.5% was used to bring
indomethacin into solution. All drug concentrations are
expressed as the final molar concentration in the organ
chamber.
Data Analysis
At least 8 animals were included in each experimental group.
Data are expressed as mean±SEM. Vasorelaxation evoked by acetylcholine
is expressed as percent inhibition of the contraction evoked by
predetermined doses of phenylephrine (see above).
Concentrations of ACh producing half-maximal inhibition of the
phenylephrine contractile effect (IC50) and
maximum relaxation effect were estimated by linear regression
analysis (fitted to the Hill equation) from log
concentration-response curves and expressed as -log IC50
and percent of maximal relaxation. Statistical evaluation of the data
was carried out by two-way ANOVA with Bonferronis t test
for multiple comparisons and Students t test. In all
comparisons, values of P<.05 were considered to indicate
significant differences between or among the means.
| Results |
|---|
|
|
|---|
|
After incubation of the rings with the NOS inhibitor L-NAME (10-5 mol/L)17 for 30 minutes, ACh-induced relaxation was significantly impaired in both aortic segments from pregnant and nonpregnant rats. However, L-NAME inhibition of ACh-induced relaxation showed important differences depending on the aortic segment or the pregnancy status, ie, ACh maximum relaxation in the presence of L-NAME was reduced to 15.6[±6.3]% and -4.3[±2.5]% (P<.05) in the thoracic aortic rings from nonpregnant and pregnant rats, respectively (Fig 2), whereas ACh-induced maximum relaxation in the presence of L-NAME was 25.3[±4.8]% (pregnant) and 45.0[±11.2]% (nonpregnant) (P<.05) in the abdominal aortic segment (Fig 3).
|
|
To further support the relative NO participation in the ACh-induced relaxation, we evaluated vascular NO production by measuring in vitro release of nitrites from abdominal or thoracic aortic rings coming from pregnant and nonpregnant rats. As seen in Fig 4, basal nitrite production was higher in the rings from pregnant rats in both segments, thoracic and abdominal. Values obtained were 0.39[±0.01] and 0.24[±0.02]x10-6 mol · mg-1 · 30 min-1, pregnant and nonpregnant, respectively, in the thoracic aorta (P<.05). For the abdominal segment, values were 0.29[±0.06] and 0.13[±0.02]x 10 -6 mol · mg-1 · 30 min-1 for pregnant and nonpregnant rats, respectively, even when these data did not attain statistical significance.
|
When arteries were stimulated with 10-5 mol/L ACh, differences in the nitrite production were evident. In the thoracic segment, aortic rings from the pregnant rats released increased amounts of NO2- (0.75[±0.04]x10-6 mol · mg-1 · 30 min-1) compared with aortas from the nonpregnant animals (0.54[±0.02]x10-6 mol · mg-1 · 30 min-1) (P>.05). However, ACh stimulation of rings from the abdominal aortic segment did not show differences in nitrite production when comparing rings from pregnant and nonpregnant animals (0.42[±0.07] and 0.39[±0.08]x10-6 mol · mg-1 · 30 min-1, respectively) (Fig 4).
We explored PGI2 participation by incubating the arteries with the cylooxygenase inhibitor indomethacin (10-5 mol/L). As seen in Fig 2, cyclooxygenase inhibition in the thoracic aortic rings by indomethacin did not affect ACh-induced relaxation in the rings from pregnant and nonpregnant rats. Similar results were observed in the aortic rings from the abdominal segment (Fig 3).
Cytochrome P450 AA metabolism inhibition by clotrimazole (10-5 mol/L) did not affect ACh-induced maximal relaxation of the abdominal or thoracic aortic rings from nonpregnant rats. Also, relaxation of thoracic rings from pregnant animals was not affected (Figs 2 and 3). By contrast, clotrimazole presence significantly decreased maximal relaxation in the abdominal aorta rings from pregnant animals (110.5[±7.4]% and 73.0[±3.1]% control and clotrimazole-treated, respectively; P<.05) without significantly changing the acetylcholine EC50 (0.20[±0.05]x10-6 mol/L and 0.41[±0.10]x106 mol/L control and clotrimazole-treated, respectively). Additionally, clotrimazole pretreatment modified ACh EC50 values in the thoracic segment of pregnant rats, with values of 0.10[±0.01]x10-6 µmol/L and 0.74[±0.14] x10-6 µmol/L (P<.05) for control and clotrimazole-treated rats, respectively.
Moreover, the combination of clotrimazole and L-NAME totally (96.5%) prevented ACh-induced vasorelaxation in all arteries tested.
| Discussion |
|---|
|
|
|---|
We found that pregnancy enhances ACh-induced relaxation of the thoracic and abdominal rat aorta. This effect of pregnancy has been reported on the uterine, mesenteric, and carotid arteries of guinea pigs and is explained as being a result of increased synthesis and release of EDRF/NO.8 11 Although there is some evidence that appears to implicate increased NO biosynthesis as a key mechanism of gestational vasodilation, other studies fail to support this notion. For example, it has been reported that basal cGMP synthesis is not different between aortas from gravid and virgin rats.20 In addition, NO synthase inhibition failed to augment vasoconstrictor responses to a greater extent in small mesenteric arteries from gravid rats; thus, it was concluded that basal NO synthesis is not increased during pregnancy in the resistance vessels.21 22
In support of NO involvement, our data show that L-NAME pretreatment abolished the relaxation induced by ACh in the thoracic aorta of pregnant and nonpregnant rats. Actually, a contractile effect of ACh in the vessels from pregnant animals was noticed, suggesting that NO is the main mediator of ACh relaxation effect in this aortic segment. On the other hand, the inhibitory effect of L-NAME was less evident in the abdominal segment of pregnant and nonpregnant rats, implying a segmental aortic difference in the mechanisms responsible for the endothelium-derived relaxation.
Basal release of NO measured as total nitrites was higher in the thoracic than in the abdominal segment of the aorta from pregnant and nonpregnant rats, respectively. Specifically, basal release of nitrites from gestating animals aortas was significantly higher than that from nonpregnant rats (Fig 4). Our results are consistent with the report of Conrad et al,23 24 who found increased nitrite excretion and increased urinary and circulating cGMP during gestation. Interestingly, ACh-stimulated nitrite release was significantly increased in the thoracic aorta rings from gravid rats compared with the production of the nonpregnant animals, but such a difference could not be seen in the abdominal rings during pregnancy (Fig 4), which gives support to the hypothesis of different endothelium-derived mediators between thoracic and abdominal segments of the rat aorta.
The role of endogenous prostaglandins in pregnancy has been extensively studied in humans and animals. It has been suggested that vasodilator prostaglandins may oppose the action of vasoconstrictors,25 but other investigators have obtained conflicting results. Paller et al26 showed that treatment with meclofenamate reversed the blunted norepinephrine pressor response in pregnant rats, but this could not be reproduced by Conrad et al with indomethacin or meclofenamate pretreatment.27 In our study, aortic rings incubated with indomethacin produced no significant differences in the concentration-response curves to ACh. It seems therefore that PGI2 (or another vasodilator eicosanoid) participation does not explain the augmented sensibility to ACh displayed by the aortic rings (neither thoracic nor abdominal) from pregnant rats.
Our findings suggest that an endothelium-derived vasorelaxant substance(s) other than PGI2 or NO is participating in the effects of ACh in the abdominal segment compared with the thoracic one, and this points to regionalized differences in the mechanisms of relaxation of this conduit vessel. Our results are consistent with the findings of Zygmunt et al,28 who found evidence of the existence of an endothelium-dependent relaxant pathway distinct from NO in the rat hepatic and aorta arteries. In this way, the increased (L-NAME resistant) relaxation in the abdominal aortic segments from pregnant rats may be related to a greater participation of an EDRF distinct from NO (and PGI2), probablyby exclusionthe EDHF.
Regional variations in the response of the rabbit thoracic aorta to contractile agonists have previously been reported.29 30 Recently, Gregg et al9 reported regionalization of endothelium-dependent relaxation in the thoracic aorta of pregnant and nonpregnant guinea pigs. These authors attribute such variations along the length of the aorta to either differences in muscarinic receptor number or affinity or differences in the receptor transduction system. Also, the rat aorta has shown differences in the activity of reticulum sarcoplasmic Ca2+ transport rate between the thoracic and abdominal segment.31 These findings may indicate differences in metabolic or mechanical properties of the two segments of the artery traditionally considered as a conduit unit.
As mentioned before, an increase in the generation of endothelium-derived vasorelaxant substances other than NO or prostaglandins could explain, in part, the increased response to ACh and contribute to the vasodilatation seen in pregnancy. Unidentified mechanisms other than prostaglandins or NO have been postulated to account for the decreased responses to vasoconstrictors during pregnancy.12 Our results show a decrease in ACh-induced relaxation during pregnancy in aortic rings incubated with the cyt P450 enzyme inhibitor clotrimazole. This effect was more evident in the abdominal compared with the thoracic aortic rings of pregnant rats. The latter suggests that a cyt P450derived epoxide may be participating to a higher degree in the pregnancy vascular changes observed in the abdominal segment. Many studies have implicated the involvement of cyt P450 enzymes in endothelium-dependent relaxation.32 These enzymes are capable of generating potent vasorelaxant products such as epoxyeicosatrienoic acids (EETs) from arachidonic acid.33 EETs elicit a potent vasodilatory effect and can be synthesized in endothelial cells,34 so it has been recently suggested that EDHF may be a cyt P450derived epoxide such as EETs.33 Actually, previous studies with pulmonary and aorta arteries of the rat proved that membrane hyperpolarization accounts for 20% to 25% of the relaxation by ACh of noradrenaline-induced tone,35 and, in addition, it has been shown that endothelium-dependent hyperpolarization to ACh is significantly diminished by cyt P450 inhibitors such as clotrimazole.32 36
On the other hand, Chen et al36 observed that endothelium-dependent hyperpolarization to ACh was obtained only at high levels of ACh stimulation in rat mesenteric arteries in which the cyt P450 enzyme activity was induced. In agreement with this observation, results from the present study show an effect of clotrimazole only at the higher ACh concentrations (Figs 2 and 3). Since modulation of cyt P450 enzyme activities results in changes in endothelium-dependent relaxation,36 and cyt P450 activity can be influenced by the hormonal environment during pregnancy,37 38 the results obtained in this study are highly suggestive that at least partially, and in a regionalized manner, pregnancy-dependent responses to ACh are mediated by cyt P450derived EDHF/EETs.
In summary, the present study using thoracic and abdominal aortic rings from pregnant and nonpregnant rats suggests that ACh-induced, endothelium-dependent vasodilation in the abdominal segment is mediated only in part by NO, the remainder apparently due to an endothelium-derived hyperpolarizing vasodilator, cyt P450dependent via metabolism of arachidonic acid, which may be EDHF/EET. Furthermore, our data suggest that pregnancy enhanced the stimulated release of this factor from abdominal aorta. On the contrary, the agonist-stimulated release of endothelium-derived NO is a more important regulatory factor in the thoracic segments. This study confirms that the increase in thoracic aorta ACh relaxation from pregnant animals seems to be first mediated by NO. Endogenous prostaglandins do not appear to be involved in the increased vascular responses to ACh in pregnant rats.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received March 18, 1997; first decision April 24, 1997; accepted May 12, 1997.
| References |
|---|
|
|
|---|
2. Gant N, Daley G, Chant S, Whelley P, MacDonald P. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689.[Medline] [Order article via Infotrieve]
3. Chesley LC, Talledo E, Bohler CS, Zuspan FP. Vascular reactivity to angiotensin II and catecholamines in pregnant and nonpregnant women. J Clin Invest. 1965;91:837-847.
4. Ferris TF. Pregnancy, preeclampsia and the endothelial cell. N Engl J Med. 1991;325:1439-1440.[Medline] [Order article via Infotrieve]
5. Paller MS, Gregorini G, Thomas EF. Pressor responsiveness in pseudopregnant and pregnant rats: role of maternal factors. Am J Physiol. 1989;26:R866-R871.
6. Hennesy A, Gillin A, Horvath J. Cardiovascular research in pregnancy: the role of animal models. Hypertension in Pregnancy. 1993;12:413-437.
7. Boonshaft B, OConnell JM, Hayes JM, Schreiner
GE. Serum renin activity during normal pregnancy: effect of
alterations of posture and sodium intake. J Clin
Endocrinol Metab. 1968;28:1641-1647.
8. Weiner CP, Liu KZ, Thompson L, Herrig J, Chestnut D. Effect of pregnancy on endothelium and smooth muscle: their role in reduced adrenergic sensitivity. Am J Physiol. 1991;261:H1271-H1283.
9. Gregg AR, Thompson LP, Herrig JE, Weiner CP. Regionalization of endothelium dependent relaxation in the thoracic aorta of pregnant and nonpregnant guinea pigs. J Vasc Res. 1995;32:106-111.[Medline] [Order article via Infotrieve]
10. Lin Al, Gonzalez R, Carey KD, Shain SA.
Estradiol-17ß affects estrogen receptor distribution and
elevates progesterone receptor content in baboon aorta.
Arteriosclerosis. 1986;6:495-505.
11. Nathan L, Cuevas J, Chaudhri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol. 1995;114:955-960.[Medline] [Order article via Infotrieve]
12. Weiner CP, Thompson LP, Liu KZ, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol. 1992;166:1171-1181.[Medline] [Order article via Infotrieve]
13. Umans JG, Lindheimer M, Barron W. Pressor effect of endothelium-derived relaxing factor inhibition in conscious virgin and gravid rats. Am J Physiol. 1990;259:F293-F296.[Medline] [Order article via Infotrieve]
14. Chu ZM, Beilin LJ. Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. Br J Pharmacol. 1993;109:322-329.[Medline] [Order article via Infotrieve]
15. Bobadilla RA, Castillo C, Valencia I, Larios FJ, Hong E. Segmental aortic differences in vascular responses during pregnancy. Proc West Pharmacol Soc. 1996;39:37-38.[Medline] [Order article via Infotrieve]
16. Furchgott RF, Bhadrakom S. Reactions of strips
of rabbit aorta to epinephrine, isopropylarterenol, sodium
nitrite and other drugs. J Pharmacol Exp Ther. 1953;108:129-143.
17. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.[Medline] [Order article via Infotrieve]
18. Rosolowsky M, Campbell WB. Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.[Medline] [Order article via Infotrieve]
19. Capdevila J, Gil L, Orellana M, Marnett LJ, Mason JI, Yadagiri P, Falck JR. Inhibitors of cyt P450 dependent arachidonic acid metabolism. Arch Biochem Biophys. 1988;261:257-263.[Medline] [Order article via Infotrieve]
20. Whittemore SL, McLaughlin MK, Davidge ST, Conrad KP. Effect of pregnancy on vascular cGMP production and vasorelaxation in the rat. Hypertension in Pregnancy. 1994;13:227-244.
21. Davidge ST, McLaughlin MK. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from pregnant rat. Am J Obstet Gynecol. 1992;167:1691-1698.[Medline] [Order article via Infotrieve]
22. Pascoal IF, Lindheimer MD, Nalbantian C, Umans JG. Contraction and endothelium-dependent relaxation in mesenteric microvessels from pregnant rats. Am J Physiol. 1995;269:H1899-H1904.[Medline] [Order article via Infotrieve]
23. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993;7:566-571.[Abstract]
24. Conrad KP, Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989;257:R847-R853.[Medline] [Order article via Infotrieve]
25. Gant NF, Whalley PJ, Everett RB, Worley RJ, MacDonald PC. Control of vascular reactivity in pregnancy. Am J Kidney Dis. 1987;9:303-307.[Medline] [Order article via Infotrieve]
26. Paller MS. Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressine in pregnant rats. Am J Physiol. 1984;247:H100-H108.[Medline] [Order article via Infotrieve]
27. Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy: serial studies in chronically instrumented conscious rats. J Clin Invest. 1986;77:236-245.[Medline] [Order article via Infotrieve]
28. Zygmunt PM, Grundemar L, Högestätt
DE. Endothelium-dependent relaxation
resistant to
N
-nitro-L-arginine in the rat
hepatic artery and aorta. Acta Physiol Scand. 1994;152:107-114.[Medline]
[Order article via Infotrieve]
29. Altura BM, Altura BT. Heterogeneity of drug receptors in different segments of rabbit thoracic aorta. Eur J Pharmacol. 1970;12:44-52.[Medline] [Order article via Infotrieve]
30. Somlyo AV, Sandberg RL, Somlyo AP.
Pharmacologically heterogeneous smooth muscle cell
distribution in blood vessels. J Pharmacol Exp
Ther. 1965;149:106-149.
31. Levitsky DO, Clergue M, Lambert F, Souponitskaya MV, Le
Jemtel TH, Lecarpentier Y, Lompré AM. Sarcoplasmic
reticulum calcium transport and Ca-ATPase gene expression in thoracic
and abdominal aortas of normotensive and spontaneously hypertensive
rats. J Biol Chem. 1993;268:8325-8331.
32. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995;16:23-30.[Medline] [Order article via Infotrieve]
33. Campbell WB, Gebremedhin D, Pratt PF, Harder DR.
Identification of epoxyeicosatrienoic acids as
endothelium-derived hyperpolarizing factors.
Circ Res. 1996;78:415-423.
34. Abraham NG, Pinto A, Mullane KM, Levere RD, Spokas
E. Presence of cytochrome P450 dependent
monooxygenase in intimal cells of hog aorta.
Hypertension. 1985;7:899-904.
35. Chen G, Suzuki H, Weston A. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol. 1988;95:1165-1174.[Medline] [Order article via Infotrieve]
36. Chen G, Cheung DW. Modulation of
endothelium-dependent
hyperpolarization and relaxation to acetylcholine
in rat mesenteric artery by cytochrome P450 enzyme activity.
Circ Res. 1996;79:827-833.
37. Matsubara S, Yamamoto S, Sogawa K, Yokotani N,
Fujii-Kuriyama Y, Haniu M, Shively JE, Gotoh O, Kusunose E, Kusunose
M. cDNA cloning and inducible expression during pregnancy of the
mRNA for rabbit pulmonary prostaglandin
-hydroxylase (cytochrome P-450 p-2). J Biol
Chem. 1987;27:13366-13371.
38. Powell WS.
-Oxidation of
prostaglandins by lung and liver microsomes. Changes in
enzyme activity induced by pregnancy, pseudo-pregnancy and progesterone
treatment. J Biol Chem. 1978;253:6711-6716.
This article has been cited by other articles:
![]() |
K. A. Hagedorn, C.-L. Cooke, J. R. Falck, B. F. Mitchell, and S. T. Davidge Regulation of Vascular Tone During Pregnancy: A Novel Role for the Pregnane X Receptor Hypertension, February 1, 2007; 49(2): 328 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meziani, B. Van Overloop, F. Schneider, and A. Gairard Parathyroid Hormone-Related Protein-induced Relaxation of Rat Uterine Arteries: Influence of the Endothelium During Gestation Reproductive Sciences, January 1, 2005; 12(1): 14 - 19. [Abstract] [PDF] |
||||
![]() |
L. Brawley, C. Torrens, F. W. Anthony, S. Itoh, T. Wheeler, A. A. Jackson, G. F. Clough, L. Poston, and M. A. Hanson Glycine rectifies vascular dysfunction induced by dietary protein imbalance during pregnancy J. Physiol., January 15, 2004; 554(2): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mateev, A. H. Sillau, R. Mouser, R. E. McCullough, M. M. White, D. A. Young, and L. G. Moore Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H820 - H829. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez-Orgado, R. Gonzalez, S. Tovar, J. Marin, M. Salaices, and M. J. Alonso Administration of N{omega}-L-Arginine Methyl Ester (L-NAME) Impairs Endothelium-Dependent Relaxation in Gravid But Not Nongravid Rats Reproductive Sciences, February 1, 2003; 10(2): 74 - 81. [Abstract] [PDF] |
||||
![]() |
S. Veerareddy, C.-L. M. Cooke, P. N. Baker, and S. T. Davidge Vascular adaptations to pregnancy in mice: effects on myogenic tone Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2226 - H2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Xu, R. A. Santizo, H. M. Koenig, and D. A. Pelligrino Chronic estrogen depletion alters adenosine diphosphate-induced pial arteriolar dilation in female rats Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2105 - H2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.J.D. Lucca, A.S.O. Adeagbo, and N.L. Alsip Oestrous cycle and pregnancy alter the reactivity of the rat uterine vasculature Hum. Reprod., December 1, 2000; 15(12): 2496 - 2503. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Littleton-Kearney, D. M. Agnew, R. J. Traystman, and P. D. Hurn Effects of estrogen on cerebral blood flow and pial microvasculature in rabbits Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1208 - H1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.J.D. Lucca, A.S.O. Adeagbo, and N.L. Alsip Influence of oestrous cycle and pregnancy on the reactivity of the rat mesenteric vascular bed Hum. Reprod., April 1, 2000; 15(4): 961 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text] |
||||
![]() |
M. F. V. Dantas, M. Urban, D. Spray, M. H. Catelli de Carvalho, and R. d. C. A. T. Passaglia Increased Acetylcholine-Induced Vasodilation in Pregnant Rats : A Role for Gap Junctional Communication Hypertension, October 1, 1999; 34(4): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shern-Brewer, N. Santanam, C. Wetzstein, J. White-Welkley, and S. Parthasarathy Exercise and Cardiovascular Disease : A New Perspective Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1181 - 1187. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |